Trademark: 88335576
Word
OCELIAN
Status
Dead
Status Code
606
Status Date
Monday, October 10, 2022
Serial Number
88335576
Mark Type
4000
Filing Date
Tuesday, March 12, 2019
Published for Opposition
Tuesday, July 9, 2019
Abandoned Date
Monday, October 10, 2022

Trademark Owner History
BIOFARMA - Owner At Publication
BioFarma - Original Applicant

Classifications
9 Apparatus and equipment for processing data and information, namely, apparatus for recording, transmission, processing and reproduction of sound, images or data; Apparatus and equipment for processing data and information, namely, computer hardware and downloadable software, for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Cloud servers ; Downloadable cloud-computing software for medical use ; downloadable computer programs for providing information on health and wellness, for entering new medical patient data into a database containing pre-recorded medical patient data, for managing and analyzing medical patient data within the database, for users to track their symptoms and record their treatments, for users to track physical activity and vital signs, for accessing and aggregating immunization data for use by health care providers, for tracking, recording and sharing healthcare information; downloadable computer software for analyzing, storing and monitoring of physiological data, including diagnostic, monitoring and warning tools; Personal digital assistants; downloadable data analysis software for use by health care providers to customize treatments based on patient profiles; Downloadable mobile software application for medical professionals and patients featuring information and related diagnostic data input from remote locations via electronic patient monitoring devices that feed information to the mobile application for use by medical professionals for purposes of monitoring and diagnosing medical conditions; downloadable artificial intelligence software for healthcare in the field of medical diagnostics and medical monitors, downloadable artificial intelligence software for the analysis of patient data, medication information and drug interactions
35 Collection, compilation and storage of data into computer databases; Updating, processing and maintenance of data in computer databases; Business advice and consultancy relating to financing business data analytics; Systemization of information into computer databases; Compilation of statistics; Business research and data analysis services in the field of genomics, medicine and life sciences; Business research and data analysis services in the field of cancer research, diagnostics, disease classification and personalized medicine; Providing an on-line database providing business intelligence in the fields of medical devices, pharmaceuticals, and life sciences; all the aforesaid being provided in relation with the medical and pharmaceutical field
44 Medical services; Providing medical testing services for diagnostic or treatment purposes and information in the field of personalized medicine; Advisory services relating to health; Pharmaceutical advice; Telemedicine services; Medical diagnostic testing, monitoring and reporting services; Medical reporting services, namely, compilation of medical reports; consultancy and information services relating to medical and pharmaceutical products; health consultancy and health counseling; health screening services in the fields of human physiology, activity, sleep, sleep apnea, cardiovascular health, dermatology, hearing, neurology, cancer, endocrinology, hormone and metabolic health; Medical diagnosis and treatment of cancer; medical evaluation of cancer, of the evolution of solid tumors during cancer treatment
10 Medical analysis instruments to follow tumor imaging ; Medical diagnostic instruments to follow tumor imaging ; Medical device for detecting cancer; Medical device for treating cancer
42 Providing temporary use of non-downloadable cloud-based software for accessing, storing and analyzing imaging data related to tumors and tumor progression
The wording "OCELIAN" has no meaning in a foreign language.

Trademark Events
Oct 11, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 10, 2022
Abandonment - No Use Statement Filed
Mar 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Mar 4, 2022
Sou Extension 5 Granted
Mar 1, 2022
Sou Extension 5 Filed
Mar 1, 2022
Sou Teas Extension Received
Sep 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Aug 30, 2021
Sou Extension 4 Granted
Aug 30, 2021
Sou Extension 4 Filed
Aug 30, 2021
Sou Teas Extension Received
Mar 3, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 1, 2021
Sou Extension 3 Granted
Mar 1, 2021
Sou Extension 3 Filed
Mar 1, 2021
Sou Teas Extension Received
Sep 3, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 1, 2020
Sou Extension 2 Granted
Sep 1, 2020
Sou Extension 2 Filed
Sep 1, 2020
Sou Teas Extension Received
Mar 4, 2020
Notice Of Approval Of Extension Request E-Mailed
Mar 2, 2020
Sou Extension 1 Granted
Mar 2, 2020
Sou Extension 1 Filed
Mar 2, 2020
Sou Teas Extension Received
Mar 2, 2020
Assigned To Examiner
Nov 18, 2019
Applicant/Correspondence Changes (Non-Responsive) Entered
Nov 18, 2019
Case Assigned To Intent To Use Paralegal
Oct 10, 2019
Teas Post Publication Amendment Received
Sep 3, 2019
Noa E-Mailed - Sou Required From Applicant
Jul 9, 2019
Official Gazette Publication Confirmation E-Mailed
Jul 9, 2019
Published For Opposition
Jun 19, 2019
Notification Of Notice Of Publication E-Mailed
Jun 6, 2019
Approved For Pub - Principal Register
Jun 6, 2019
Examiner's Amendment Entered
Jun 6, 2019
Notification Of Examiners Amendment E-Mailed
Jun 6, 2019
Examiners Amendment E-Mailed
Jun 6, 2019
Examiners Amendment -Written
Jun 6, 2019
Previous Allowance Count Withdrawn
May 28, 2019
Withdrawn From Pub - Og Review Query
May 9, 2019
Approved For Pub - Principal Register
May 9, 2019
Examiner's Amendment Entered
May 9, 2019
Notification Of Examiners Amendment E-Mailed
May 9, 2019
Examiners Amendment E-Mailed
May 9, 2019
Examiners Amendment -Written
May 6, 2019
Teas/Email Correspondence Entered
May 6, 2019
Correspondence Received In Law Office
Apr 26, 2019
Assigned To Lie
Apr 18, 2019
Teas Response To Office Action Received
Apr 2, 2019
Notification Of Non-Final Action E-Mailed
Apr 2, 2019
Non-Final Action E-Mailed
Apr 2, 2019
Non-Final Action Written
Apr 1, 2019
Assigned To Examiner
Mar 29, 2019
New Application Office Supplied Data Entered
Mar 15, 2019
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24